ArcherDX, Inc. Announces the Appointment of Steven J. Kafka, Ph.D. as Executive Chairman of the Board of Directors https://archerdx.com/archerdx-inc-announces-the-appointment-of-steven-j-kafka-ph-d-as-executive-chairman-of-the-board-of-directors/

ArcherDX, Inc. Announces the Appointment of Steven J. Kafka, Ph.D. as Executive Chairman of the Board of Directors BOULDER, Colo., May, 29, 2019 /PRNEWSWIRE/– ArcherDX, […]
ArcherDX announces collaboration with University College London to Investigate the Novel Use of Cell-Free Circulating Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients https://archerdx.com/archerdx-announces-collaboration-with-university-college-london-to-investigate-the-novel-use-of-cell-free-circulating-tumor-dna-to-detect-disease-recurrence-in-lung-cancer-patients/

ArcherDX announces collaboration with University College London to Investigate the Novel Use of Cell-Free Circulating Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients […]
ArcherDX, Inc. Announces Expansion of Executive Leadership Team as Company Continues to Experience Rapid Growth https://archerdx.com/archerdx-inc-announces-expansion-of-executive-leadership-team-as-company-continues-to-experience-rapid-growth/

ArcherDX, Inc. Announces Expansion of Executive Leadership Team as Company Continues to Experience Rapid Growth BOULDER, Colo., March 5, 2019 — ArcherDX, Inc., a molecular […]
ArcherDX, Inc. Announces Broad-Based Strategic Collaboration with Genosity https://archerdx.com/archerdx-inc-announces-broad-based-strategic-collaboration-with-genosity/

ArcherDX, Inc. Announces Broad-Based Strategic Collaboration with Genosity February 12, 2019 BOULDER, CO-ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance […]
ArcherDX, Inc. Acquires Baby Genes, a Genetics-Based Personalized Medicine Company https://archerdx.com/archerdx-inc-acquires-baby-genes-a-genetics-based-personalized-medicine-company/

ArcherDX, Inc. Acquires Baby Genes, a Genetics-Based Personalized Medicine Company January 30, 2019 BOULDER, CO-ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions […]
ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests https://archerdx.com/archerdx-and-illumina-partner-for-future-to-co-market-portfolio-of-planned-in-vitro-diagnostic-ivd-tests/

ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests Co-marketing partnership to drive awareness of ArcherDX IVD products and […]
ArcherDX’s Companion Diagnostic Test for both Liquid Biopsy and Tissue Specimens Granted Breakthrough Device Designation by U.S. Food and Drug Administration https://archerdx.com/archerdxs-companion-diagnostic-test-for-both-liquid-biopsy-and-tissue-specimens-granted-breakthrough-device-designation-by-u-s-food-and-drug-administration/

ArcherDX’s Companion Diagnostic Test for both Liquid Biopsy and Tissue Specimens Granted Breakthrough Device Designation by U.S. Food and Drug Administration January 8, 2019 BOULDER, […]
Merck KGaA, Darmstadt, Germany Selects ArcherDX, Inc. for Strategic Global Companion Diagnostic Test Development Collaboration https://archerdx.com/merck-kgaa-darmstadt-germany-selects-archerdx-inc-for-strategic-global-companion-diagnostic-test-development-collaboration/

Merck KGaA, Darmstadt, Germany Selects ArcherDX, Inc. for Strategic Global Companion Diagnostic Test Development Collaboration October 3, 2018 BOULDER, CO-ArcherDX, a molecular technology company dedicated […]
Washington University, ArcherDX, Inc. partner for MRD in pediatric AML sequencing study https://archerdx.com/washington-university-archerdx-inc-partner-for-mrd-in-pediatric-aml-sequencing-study/

Washington University, ArcherDX, Inc. partner for MRD in pediatric AML sequencing study April 12, 2018 BOULDER, CO-Washington University in St. Louis and ArcherDX, Inc. will […]
ArcherDX, Inc. and Ambry Genetics to provide immune repertoire and CAR-T- related sequencing services https://archerdx.com/archerdx-inc-and-ambry-genetics-to-provide-immune-repertoire-and-car-t-related-sequencing-services/

ArcherDX, Inc. and Ambry Genetics to provide immune repertoire and CAR-T- related sequencing services Partnership accelerates the development of promising new immunotherapies March 26, 2018 […]